China Pharma Holdings (CPHI) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
China Pharma Holdings (CPHI) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.34 Mn | 41.03 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.30% |
| Dec 31, 2025 | -0.22% |
| Sep 30, 2025 | 8.39% |
| Jun 30, 2025 | -111.66% |
| Mar 31, 2025 | -3.52% |
| Dec 31, 2024 | 42.06% |
| Sep 30, 2024 | -9.79% |
| Jun 30, 2024 | -11.40% |
| Mar 31, 2024 | -18.01% |
| Dec 31, 2023 | 30.49% |
| Sep 30, 2023 | 15.97% |
| Jun 30, 2023 | 10.07% |
| Mar 31, 2023 | -10.15% |
| Dec 31, 2022 | 38.03% |
| Sep 30, 2022 | 18.47% |
| Jun 30, 2022 | 17.24% |
| Mar 31, 2022 | -1.26% |
| Dec 31, 2021 | -1.75% |
| Sep 30, 2021 | 13.93% |
| Jun 30, 2021 | 19.59% |